Please login to the form below
lonafarnib
This page shows the latest lonafarnib news and features for those working in and with pharma, biotech and healthcare.
Deals in development
It doubled its phase III anticancer portfolio, with Novacea's high-dose capsule formulation of calcitriol, DN-101 (Asentar), joining its farnesyl protein transferase inhibitor lonafarnib (Sarasar) at the market end
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Lonafarnib: promising results in first-ever trial for progeria
Ground-breaking results for lonafarnib. Lonafarnib (Sarasar) is an orally active FTI under clinical development with Schering-Plough (now Merck &Co) in capsule formulation for the treatment of progeria and various ... Lonafarnib and FTIs as a class have
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Account Executive
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director
-
Salary TBC
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Account Director, Medical Education
-
Salary TBC
-
Account Supervisor
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
Subscribe to our email news alerts
- Genital herpes vaccine candidate heads for human studies
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- FDA advisors say no to empagliflozin in type 1 diabetes
- Novartis makes case for NASH candidate tropifexor
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- AbbVie sells $30bn of bonds ahead of Allergan merger
- RWE Blog 3: Is real-world evidence the holy grail
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- BeiGene bags FDA approval for first product Brukinsa in lymphoma
- Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
- Shionogi scores FDA approval for new cUTI antibiotic
PMHub
HAVAS Just::
HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....
Latest intelligence
- RWE Blog 3: Is real-world evidence the holy grail
- We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
Quick links
Infographics
